FDA Clearance Tracker · K250286
Rapid2 Magnetic Stimulators (Magstim Rapid2, Magstim Super Rapid2, Magstim Super Rapid2 Plus1)
Last checked: Nov 19, 2026Latest source record: Jul 3, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jul 3, 2025
Substantially Equivalent
Time to decision
153 days
Received Jan 31, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K250286
- Device name
- Rapid2 Magnetic Stimulators (Magstim Rapid2, Magstim Super Rapid2, Magstim Super Rapid2 Plus1)
- Applicant
- The Magstim Company Limited
- Applicant location
- Carmarthenshire, GB
- Received
- Jan 31, 2025
- Decided
- Jul 3, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5890
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QPL. The earliest in FDA's data is K210021, decided Jun 11, 2021.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K250286
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for The Magstim Company Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K243869 · Decided Mar 17, 2025 · 90 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
K241518 · Decided Aug 30, 2024 · 93 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.